SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000819050-20-000024
Filing Date
2020-02-28
Accepted
2020-02-28 16:10:23
Documents
8

Document Format Files

Seq Description Document Type Size
1 S-3 a20200228s3.htm S-3 523063
2 EXHIBIT 4.3 a20200228s3exhibit43.htm EX-4.3 114223
3 EXHIBIT 4.4 a20200228s3exhibit44.htm EX-4.4 121242
4 EXHIBIT 5.1 a20200228s3exhibit51.htm EX-5.1 17353
5 EXHIBIT 23.1 a20200228s3exhibit231.htm EX-23.1 3952
6 bbi_1a01.gif GRAPHIC 27959
7 bbi_2a02.gif GRAPHIC 25688
8 mblogoa03.gif GRAPHIC 4449
  Complete submission text file 0000819050-20-000024.txt   861200
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-236757 | Film No.: 20670130
SIC: 2836 Biological Products, (No Diagnostic Substances)